IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Cian Healthcare IPO is a Book Building listing on BSE SME exchange. The company is based in Pune and caters to Pharmaceutical sector. Fedex Securities is the merchant banker of Cian Healthcare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd March 2019.
Cian Healthcare IPO posted revenues of ₹ 58.76 crores and PAT of ₹ 7.00 crores in FY19 on annualised basis.
Revenue:
₹ 58.76 Cr.
EBITDA Margin:
28.16
% 
Net Worth: ₹ 25.35 Cr.
Market Capitalisation:
[●]
P/E:
21.66 times
P/BV: [●]
EV/EBITDA: [●]
Financial results of Cian Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Dec-18 | FY18 | FY17 | FY16 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 85.90 | 77.62 | 61.27 | 56.81 | |
| Net Worth | 25.35 | 16.79 | 13.04 | 10.80 | |
| Total Debt | 43.36 | 47.63 | 39.66 | 31.05 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
44.07
58.76 |
59.41 | 51.78 | 46.68 | |
EBITDA
EBITDA on annualised basis |
12.41
16.55 |
12.74 | 9.99 | 7.88 | |
PAT
PAT on annualised basis |
5.25
7.00 |
3.75 | 2.33 | 1.37 | |
Cian Healthcare IPO PAT Margin is 11.91 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Cian Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Dec-18 | FY18 | FY17 | FY16 |
|---|---|---|---|---|
| EBITDA Margin (%) | 28.16 | 21.44 | 19.29 | 16.88 |
| PAT Margin (%) | 11.91 | 6.31 | 4.50 | 2.93 |
| EPS (₹) | 3.11 | 2.24 | 1.33 | 0.84 |
| ROE (%) | 20.71 | 22.33 | 17.87 | 12.69 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 6.11 | 4.83 | 3.80 | 2.41 |
| Debt to Equity | 1.71 | 2.84 | 3.04 | 2.88 |
The market Capitalisation of Cian Healthcare IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Cian Healthcare IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Cian Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Cian Healthcare IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Cian Healthcare IPO has a Price-to-Earnings (PE) ratio of 21.66 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Cian Healthcare IPO reported revenue of ₹ 58.76 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Cian Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Cian Healthcare recorded an EBITDA of ₹ 16.55 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Cian Healthcare Profit After Tax (PAT) is ₹ 7.00 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 58.76 Cr.
EBITDA Margin:
28.16
%
Net Worth: ₹ 25.35 Cr.
Market Capitalisation:
[●]
P/E:
21.66 times
P/BV: [●]
EV/EBITDA: [●]
Cian Healthcare operates in Pharmaceutical and . The Issue is listed on BSE SME in May, 2019. Cian Healthcare IPO size was 37.92 with Issue price of 61.00 .
Merchant Banker(s) of Cian Healthcare IPO: Fedex Securities Private Limited
Cian Healthcare IPO subscription was 1.25 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Cian Healthcare IPO listed at a listing price of 61.50 against the offer price of 61.00.
The current market price of Cian Healthcare is 3.12.
Why Us?
